ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0471

Understanding the Role of the Complement System in Insulin Resistance and Metabolic Syndrome in Patients with Rheumatoid Arthritis

Jose Viotti-Serra1, Maria Garcia-Gonzalez2, Fuensanta Gomez-Bernal1, Juan Carlos Quevedo-Abeledo3, Miguel Angel Gonzalez-Gay4 and ivan Ferraz-Amaro5, 1Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain, 2Hospital Universitario de Canarias, SC Tenerife, Canarias, Spain, 3Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Canarias, Spain, 4University of Cantabria, Fundación Jimenez Díaz, Madrid, Madrid, Spain, 5Rheumatology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain

Meeting: ACR Convergence 2024

Keywords: complement, metabolic syndrome, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The complement (C) system has been associated with the etiopathogenesis of rheumatoid arthritis (RA). Insulin resistance (IR) and metabolic syndrome are prevalent among RA patients. The aim of this study was to explore the relationship between a comprehensive evaluation of the C system and IR, as well as metabolic syndrome, in RA patients.

Methods: 339 non-diabetic patients with RA were recruited. Functional assays of the three C pathways were assessed. Additionally, serum levels of individual components of the C system were measured: C1q (classical), lectin (lectin), C2, C4, and C4b (classical-lectin), factor D and properdin (alternative), C3 and C3a (common), C5, C5a, and C9 (terminal), as well as regulators factor I and C1-inhibitor. IR and beta cell function indices were calculated using the homeostatic model assessment (HOMA). Criteria for metabolic syndrome were applied. Multivariable linear regression analysis was performed to investigate the association between the C system and IR in RA patients.

Results: Spearman’s rho correlation heatmap analysis of C system pathways and IR indices is shown in Figure 1-A. In this univariable analysis, multiple significant associations were found. Most of these associations were positive (depicted in red on the correlation map). Regarding C functional tests, the classical pathway exhibited a significant negative relationship with plasma glucose levels and a positive correlation to the HOMA2-%B index. The alternative pathway showed the same associations as the classical pathway but also disclosed significant positive associations with serum insulin and C-peptide levels. Remarkably, the functional test of the lectin pathway did not show statistically significant associations with any glucose homeostasis parameter.
In terms of the C system molecules, most associations were identified for molecules situated at the upper and common segments of both the classical and alternative pathways, rather than for those within the lectin pathway or the terminal cascade of the C system (Figure 1-A). In the correlation heatmap presented in Figure 2-A, only associations with a p-value lower than 0.20 from Figure 1-A were subsequently adjusted for confounders and expressed as standardized beta coefficients. After this adjustment for covariates, most of the associations from the univariable analysis lost significance (Figure 1-B). Only the positive relation between the alternative route functional test and C-peptide and HOMA2-%B retained its significance.
Differences in C values between patients with and without metabolic syndrome is shown in Table 1. Although the functional C tests corresponding to the three cascades did not significantly differ between the groups, the values of C1q, properdin, C4, C3, and factor I were significantly higher in patients with metabolic syndrome compared to those without it after multivariable adjustment.

Conclusion: There is a positive correlation between the complement system and metabolic syndrome among non-diabetic patients with RA. This association is independent of traditional IR factors.

Supporting image 1

Figure 1. Relationship between complement system and insulin resistance. A) Spearman’s rho correlation heatmap analysis of complement system pathways glucose homeostatic molecules and insulin resistance indices. B) Multivariable standardized beta coefficients heatmap of the association between complement system (independent variable) and glucose homeostatic molecules and insulin resistance indices (dependent variable) adjusted for sex, abdominal circumference, positivity to anti-citrullinated protein antibodies, and the use of statins and methotrexate Only Spearman’s rho correlation coefficients with a p value inferior to 0.20 in [A] are tested in the multivariable regression analysis [B]. CL: classical, LE: lectin, AL: alternative, fI: factor I, fD: factor D. Significant correlation and standardized beta coefficients with a p <0.05 are depicted as *.

Supporting image 2


Disclosures: J. Viotti-Serra: None; M. Garcia-Gonzalez: None; F. Gomez-Bernal: None; J. Quevedo-Abeledo: None; M. Gonzalez-Gay: None; i. Ferraz-Amaro: AbbVie/Abbott, 5, 6, Celgene, 6, Janssen, 5, Merck/MSD, 5, 6, Pfizer, 6, Roche, 5, 6, sanofi, 6.

To cite this abstract in AMA style:

Viotti-Serra J, Garcia-Gonzalez M, Gomez-Bernal F, Quevedo-Abeledo J, Gonzalez-Gay M, Ferraz-Amaro i. Understanding the Role of the Complement System in Insulin Resistance and Metabolic Syndrome in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/understanding-the-role-of-the-complement-system-in-insulin-resistance-and-metabolic-syndrome-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/understanding-the-role-of-the-complement-system-in-insulin-resistance-and-metabolic-syndrome-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology